title: In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites.
abstract: BACKGROUND
  Infected cells recognize viral replication as a DNA damage stress and elicit the host surveillance mechanism to anti-virus infection. Modulation of the activity of tumor suppressor p53 is a key event in the replication of many viruses. They could manipulate p53 function through phosphorylation modification for their own purpose. But there is rarely research about p53 phosphorylation status in the context of HPV-E6. Therefore, we investigated whether p53 could be phosphorylated by HPV-E6.
  
  
  METHODS
  We used a mammalian green fluorescence protein (GFP) expression system to express HPV-18E6 with GFP fusion proteins (GFP-18E6) in wild-type (wt) p53 cell lines, such as 293T and MCF-7 cells to trace the traffic and subcellular location of E6 protein. By immunofluorescence technique and immunoblotting, we determined the positive phosphorylated sites of p53 and observed the distribution of phosphorylated p53 in the context of GFP-18E6.
  
  
  RESULTS
  GFP-18E6 was predominantly located in nuclei of wt p53 cell lines, and it could induce transient phosphorylation of p53 at multiple sites, such as Ser15, Ser20, and Ser392. All the three sites of phosphorylated p53s were localized in nuclei together with GFP-18E6.
  
  
  CONCLUSIONS
  In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wt p53 could be transiently phosphorylated at multiple sites.
authors.affiliation: Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, School of Medicine, Xi an Jiaotong University, Xi an, PR China. sunlina.xjtu@yahoo.com.cn
authors.forename: Lina
authors.initials: L
authors.lastname: Sun
authors.forename: Ge
authors.initials: G
authors.lastname: Zhang
authors.forename: Zongfang
authors.initials: Z
authors.lastname: Li
authors.forename: Tusheng
authors.initials: T
authors.lastname: Song
authors.forename: Chen
authors.initials: C
authors.lastname: Huang
authors.forename: Lusheng
authors.initials: L
authors.lastname: Si
mesh_terms: D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism; D064447:Checkpoint Kinase 2; D005260:Female; D049452:Green Fluorescent Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000032:analysis / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics / Q000378:metabolism*
chemical_list: C466081:E6 protein, Human papillomavirus type 8; D009856:Oncogene Proteins, Viral; D011993:Recombinant Fusion Proteins; D016159:Tumor Suppressor Protein p53; D049452:Green Fluorescent Proteins; D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases
references.citation: Oncogene. 2001 Oct 25;20(48):6994-7005
references.pmid: 11704824
references.citation: Cancer. 1987 May 15;59(10):1692-6
references.pmid: 3030526
references.citation: J Virol. 2004 Jul;78(13):7165-74
references.pmid: 15194793
references.citation: Oncogene. 2001 Nov 26;20(54):7874-87
references.pmid: 11753670
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10855-60
references.pmid: 12145320
references.citation: Oncogene. 2008 Aug 14;27(35):4854-9
references.pmid: 18438429
references.citation: J Biol Chem. 2008 Mar 7;283(10):6572-83
references.pmid: 18162465
references.citation: J Virol. 2006 Mar;80(5):2257-66
references.pmid: 16474133
references.citation: Cell Death Differ. 2006 Jun;13(6):941-50
references.pmid: 16601750
references.citation: Neoplasia. 2001 Jan-Feb;3(1):10-6
references.pmid: 11326311
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):889-900
references.pmid: 15279774
references.citation: Science. 1990 Apr 6;248(4951):76-9
references.pmid: 2157286
references.citation: J Virol. 1996 Jul;70(7):4509-16
references.pmid: 8676476
references.citation: Am J Pathol. 1995 Mar;146(3):599-604
references.pmid: 7887442
references.citation: Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
references.pmid: 1933891
references.citation: Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92
references.pmid: 8387205
references.citation: J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
references.pmid: 15753007
references.citation: Biochem J. 1999 Aug 15;342 ( Pt 1):133-41
references.pmid: 10432310
references.citation: J Exp Clin Cancer Res. 2007 Jun;26(2):241-51
references.pmid: 17725105
references.citation: Virology. 1992 Mar;187(1):343-7
references.pmid: 1736539
references.citation: Science. 1998 Sep 11;281(5383):1674-7
references.pmid: 9733514
references.citation: J Biol Chem. 2003 Sep 26;278(39):37536-44
references.pmid: 12860987
references.citation: Cancer Lett. 2007 Oct 8;255(2):219-31
references.pmid: 17582679
references.citation: J Exp Clin Cancer Res. 1999 Mar;18(1):47-52
references.pmid: 10374676
references.citation: J Exp Clin Cancer Res. 2006 Dec;25(4):515-21
references.pmid: 17310842
references.citation: Oncogene. 2000 Oct 19;19(44):5098-105
references.pmid: 11042698
references.citation: Cancer Res. 2008 Feb 1;68(3):777-82
references.pmid: 18245478
references.citation: Oncogene. 1995 Mar 2;10(5):927-36
references.pmid: 7898934
references.citation: Oncogene. 2001 Jun 21;20(28):3597-608
references.pmid: 11439323
references.citation: Cell. 1990 Dec 21;63(6):1129-36
references.pmid: 2175676
references.citation: Cell. 1993 Nov 19;75(4):765-78
references.pmid: 8242748
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10389-94
references.pmid: 10973490
references.citation: J Biol Chem. 1996 Nov 15;271(46):29380-5
references.pmid: 8910602
references.citation: Virology. 2002 Jul 20;299(1):72-87
references.pmid: 12167343
references.citation: Int J Oncol. 2002 Sep;21(3):561-7
references.pmid: 12168100